Defining Outcomes for β-cell Replacement Therapy in the Treatment of DiabetesUtilization of organs from donors after circulatory death for vascularized pancreas and islet of Langerhans transplantationDefining outcomes for beta cell replacement therapyHuman pancreatic islet three-dimensional chromatin architecture provides insights into the genetics of type 2 diabetesDefining outcomes for β-cell replacement therapy in the treatment of diabetes
author
type
label
Thierry Berney